A clearer view of research suppliers. Evidence first. Always.
PepSonar
US · EnglishOur methodology ↗
ABOUT THE DIRECTORY

Useful evidence. Clear editorial boundaries.

Our principles for sources, assessments, corrections and commercial independence.

Sources and attribution

Prefer original provider documentation, issuing-laboratory records and primary analytical references. Attribute provider claims. A linked source supports the stated observation; it does not imply validation of every claim on that website.

Originality and limits

Write original assessments of the information actually examined. Never invent a purchase, test, reviewer, testimonial or endorsement. These launch profiles reflect desk research, without a qualified scientific reviewer or clinical assessment.

Commercial independence

Payment must not purchase a favourable assessment or obscure a promotion. Include useful non-affiliate records. Label sponsored placements and disclose compensation near the first relevant recommendation.

Corrections and changes

Corrections should identify the URL, disputed statement, supporting source and observation date. Material changes belong in a profile’s change history. Submit a correction.

Research and medical information

The site covers procurement documentation and analytical literacy. It does not publish human-use dosing, injection calculators, treatment selection or unsourced claims about therapeutic benefit.

Published 31 October 2026.

Daniel Mercer
EDITORIAL PROFILE

Daniel Mercer

Senior Peptide Research Editor

I turn complex peptide research into clear, practical guides that anyone can follow. My focus is separating scientific findings from marketing hype and explaining what the evidence actually supports.

Research literacyEvidence & claimsEditorial standards